Objective To assess the effect of 12-month treatment with adalimumab on work ability,
quality of life, and fatigue in patients with active rheumatoid arthritis (RA). Methods One …

Objective: The objective of this exploratory study was to evaluate the effects and costs of a 6‐
month course of tumour necrosis factor (TNF) inhibitors on work ability, quality of life, and …

Objective: To assess the effect of 12-month treatment with adalimumab on work ability,
quality of life, and fatigue in patients with active rheumatoid arthritis (RA). Methods: One …

Objectives: To assess the relationship between disease activity and work ability, quality of
life (QoL), and fatigue in patients with RA during a 12-month course of the tumour necrosis …

Objectives: Rheumatoid arthritis (RA) is a chronic disabling disease that can jeopardize the
ability of affected individuals to participate in paid work. Our objective was to evaluate the …

Objective To evaluate the shortterm effect of adalimumab on work productivity in patients
with moderate to severe active rheumatoid arthritis (RA). Methods In a substudy of the …

Objective To compare work disability and job loss in early rheumatoid arthritis (RA) patients
receiving adalimumab plus methotrexate (adalimumab+ MTX) versus MTX alone. Methods …

OBJECTIVE: To compare the effect of adalimumab plus methotrexate (MTX) versus MTX
monotherapy on health-related quality of life (HRQOL) and work activities in patients with …

Background and objectives: Rheumatoid arthritis (RA) causes considerable disability and
often results in loss of work capacity and productivity. This study evaluated the impact of …

Objectives: To study:(I) work-loss seen as sick leave and disability pension before and after
the start of first anti-TNF therapy in Swedish regional and national RA cohorts;(II) baseline …